So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| TED-QoL / GO-QoL: Bảng câu hỏi chất lượng cuộc sống cho bệnh mắt tuyến giáp× | Bảng kiểm Triệu chứng Cường giáp× | |
|---|---|---|
| Lĩnh vực | Nội tiết học | Nội tiết học |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 2001 | 1997 |
| Người khởi xướng≠ | Caroline Terwee, Markus Gerding, Frank Dekker | Multiple authors; consensus from Endocrine Society |
| Loại≠ | Patient self-report questionnaire | Patient self-report symptom checklist |
| Công trình gốc≠ | Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779. link ↗ | Engel, G. L., Dayan, A. D., Thorn, G. W., et al. (1997). Hyperthyroidism: A multisystem disease with diverse manifestations. Adv Intern Med, 42, 55-91. link ↗ |
| Tên gọi khác | GO-QoL, Graves Ophthalmopathy Quality of Life | HSC, Hyperthyroid Symptom Inventory |
| Liên quan | 3 | 3 |
| Tóm tắt≠ | The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment. | The Hyperthyroidism Symptom Checklist is a structured assessment tool for quantifying the symptom burden of Graves' disease and other thyrotoxicosis conditions. It captures the multisystem manifestations of excess thyroid hormone: cardiovascular (palpitations, tachycardia, arrhythmia), neuropsychiatric (anxiety, tremor, insomnia), metabolic (heat intolerance, weight loss, appetite), and eye-specific symptoms (in Graves' ophthalmopathy). Used in endocrinology practice and clinical trials to monitor disease activity and treatment response. |
| ScholarGateBộ dữ liệu ↗ |
|
|